Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Amyloidosis
Open monograph to display formulary status.
No results found when searching the local formulary, see alternative searches below.
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local
BNF
Section
Eplontersen
Eplontersen
Nutrition And Metabolic Disorders, Metabolic Disorders, Amyloidosis
Inotersen
Inotersen
Nutrition And Metabolic Disorders, Metabolic Disorders, Amyloidosis
Patisiran
Patisiran
Nutrition And Metabolic Disorders, Metabolic Disorders, Amyloidosis
Tafamidis
Tafamidis
Nutrition And Metabolic Disorders, Metabolic Disorders, Amyloidosis
Vutrisiran
Vutrisiran
Nutrition And Metabolic Disorders, Metabolic Disorders, Amyloidosis
Links found
MHRA Drug Safety Update: Insulins (all types): risk of cutaneous amyloidosis at injection site (Sept 2020)
NICE TA959: Daratumumab in combination for treating newly diagnosed systemic amyloid light-chain amyloidosis